Discovery of novel fragments inhibiting O-acetylserine sulphhydrylase by combining scaffold hopping and ligand–based drug design

Author:

Magalhães Joana1,Franko Nina2,Annunziato Giannamaria1,Welch Martin3,Dolan Stephen K.3,Bruno Agostino4,Mozzarelli Andrea256,Armao Stefano7,Jirgensons Aigars8,Pieroni Marco1,Costantino Gabriele19,Campanini Barbara2

Affiliation:

1. P4T group, Department of Food and Drug, University of Parma, Parma, Italy;

2. Laboratory of Biochemistry and Molecular Biology, Department of Food and Drug, University of Parma, Parma, Italy;

3. Department of Biochemistry, Cambridge University, Cambridge, United Kingdom;

4. Experimental Therapeutics Program, IFOM – The FIRC Institute for Molecular Oncology Foundation, Milano, Italy;

5. National Institute of Biostructures and Biosystems, Rome, Italy;

6. Institute of Biophysics, CNR, Pisa, Italy;

7. Centro Interdipartimentale “Biopharmanet-tec”, Università degli Studi di Parma, Parma, Italy;

8. Latvian Institute of Organic Synthesis, Riga, Latvia;

9. Centro Interdipartimentale Misure (CIM)’G. Casnati’, University of Parma, Parma, Italy

Funder

European Union’s Horizon 2020

innovation program/Marie Sklodowska-Curie

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3